Endonovo Therapeutics, Inc. (ENDV)

Endonovo Therapeutics Revenue

Endonovo Therapeutics had revenue of $1.52K in the quarter ending September 30, 2023, a decrease of -86.13%. This brings the company's total for the last twelve months to $255.72K, up 1,699.85% year-over-year. In the year 2022, Endonovo Therapeutics had annual revenue of $135.36K with 85.15% growth. That makes Endonovo Therapeutics the 45,221st largest company in the world by revenue and 6,551st in the United States.

• Revenue (ttm): 255.72K
• Revenue Growth: +1,699.85%
• P/S Ratio: 0.35
• Revenue / Employee: 255.72K
• Employees: 1
• Market Cap: 90.38K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	135.36K	62.25K	85.15%
Dec 31, 2021	73.11K	-92.69K	-55.91%
Dec 31, 2020	165.80K	-144.37K	-46.55%
Dec 31, 2019	310.16K	226.90K	272.51%
Dec 31, 2018	83.26K	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 29, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error